| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgment of Reviewers
|
|
|
|
3 |
3 |
p.
|
artikel
|
| 2 |
An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study
|
Su, Po-Lan
|
|
|
3 |
3 |
p.
|
artikel
|
| 3 |
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
|
Kerrigan, Kathleen
|
|
|
3 |
3 |
p.
|
artikel
|
| 4 |
Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC
|
Varlotto, John M.
|
|
|
3 |
3 |
p.
|
artikel
|
| 5 |
Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia
|
Loong, Herbert H.
|
|
|
3 |
3 |
p.
|
artikel
|
| 6 |
EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States
|
Lin, Huamao M.
|
|
|
3 |
3 |
p.
|
artikel
|
| 7 |
Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry
|
Carr, Laurie L.
|
|
|
3 |
3 |
p.
|
artikel
|
| 8 |
Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
|
Antonoff, Mara B.
|
|
|
3 |
3 |
p.
|
artikel
|
| 9 |
Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report
|
Gerber, David E.
|
|
|
3 |
3 |
p.
|
artikel
|
| 10 |
Unusual Resistance Mechanisms in a Case of ROS 1-Rearranged NSCLC: A Case Report
|
Batra, Ullas
|
|
|
3 |
3 |
p.
|
artikel
|
Tijdschrift beschrijving